There are 5 papers on structural valve deterioration in aging research: 4 observational studies in people, 1 review.
5 papers study it2 more mention it3 findings
1 new paper in 30 daysSee all 7 papers on structural valve deterioration
“in the multivariable analysis, ERMPG was an independent predictor of SVD (adjusted subdistribution hazard ratio [sHR] 1.05, 95% confidence interval [CI]: 1.01-1.08; p=0.004).”
- Humans4
Upstream
1Female sex
no changein humans1HR 0.99
1 study
Female sex
no changein humans1HR 0.99
Female sex was not clearly linked with structural valve deterioration in humans after transcatheter aortic valve implantation (HR 0.99, 95% CI 0.78-1.25, P = 0.90).
“The development of SVD was comparable (hazard ratio, 0.99; 95% confidence interval, 0.78-1.25, P = 0.90)”
Humansafter transcatheter aortic valve implantationmedian follow-up of 1844 daysfemalesn = 511
Long-Term Impact of Gender Differences After Transcatheter Aortic Valve Implantation
CJC open
Associations
2Mortality
upin humans1HR 2.12
1 study
Mortality
upin humans1HR 2.12
Structural valve deterioration is associated with mortality in humans after TAVI (adjusted HR 2.12, 95% CI: 1.49-3.00).
“SVD was associated with increased 10-year rates of all-cause mortality (adjusted hazard ratio 2.12, 95% CI: 1.49-3.00; p<0.001)”
Humansafter TAVI10-year
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Early residual mean postprocedural gradient
upin humans1
1 study
Early residual mean postprocedural gradient
upin humans1
Early residual mean postprocedural gradient predicts structural valve deterioration in humans (severe aortic valve stenosis after TAVI) (adjusted sHR 1.05, 95% CI: 1.01-1.08).
“in the multivariable analysis, ERMPG was an independent predictor of SVD (adjusted subdistribution hazard ratio [sHR] 1.05, 95% confidence interval [CI]: 1.01-1.08; p=0.004).”
Humanssevere aortic valve stenosis after TAVI
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology